insights_auto
Outlook: 33.3% bullish·4.8% bearish
Go to analysischevron_right
L1RC34:BVMF
Lam Research Corp Bdr
R$29.75
0.00%
(0.00) 1D
Oct 26, 5:07:00 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for L1RC34...
Open
R$29.75
High
R$29.87
Low
R$28.78
Mkt. cap
296.68B
Avg. vol.
36.74K
Volume
323.25K
52-wk high
R$51.55
52-wk low
R$16.79
Shares outstanding
1.25B
No. of employees
24K
Open
R$29.75
High
R$29.87
Low
R$28.78
Mkt. cap
296.68B
Avg. vol.
36.74K
Volume
323.25K
52-wk high
R$51.55
52-wk low
R$16.79
Shares outstanding
1.25B
No. of employees
24K
News stories
From web sources and news partners
Trefis
·
12 hours ago
Is Lam Research Stock Cheap Enough Yet?
TradingView
·
13 hours ago
Lam Research Stocks Gain 4.3% Despite Citi's Target Cut
Investing.com
·
15 hours ago
Lam Research CEO Timothy Archer sells $7.1M in company stock
TradingKey
·
18 hours ago
Lam Research Corp Stock (LRCX) Moved Up by 4.08% on Oct 26: Key Drivers Unveiled
Profile
Lam Research Corporation is an American supplier of wafer-fabrication equipment and related services to the semiconductor industry. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices and their wiring. The company also builds equipment for back-end wafer-level packaging and for related manufacturing markets such as for microelectromechanical systems.
Lam Research was founded in 1980 by David K. Lam and is headquartered in Fremont, California. As of 2023, it was the third largest manufacturer in the Bay Area, after Tesla and Intuitive Surgical. Wikipedia
About Lam Research Corp Bdr
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 5.34B | 5.84B | 6.72B | 8.22B |
Cost of goods sold | 2.69B | 2.93B | 3.24B | 3.92B |
Cost of revenue | 2.69B | 2.93B | 3.24B | 3.92B |
Research and development expenses | 573.30M | 583.20M | 642.92M | 666.40M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 267.65M | 280.31M | 322.33M | 348.73M |
Operating expense | 840.96M | 863.51M | 965.25M | 1.02B |
Total operating expenses | 3.53B | 3.79B | 4.21B | 4.94B |
Operating income | 1.81B | 2.05B | 2.51B | 3.28B |
Other non operating income | 22.16M | -37.72M | 54.86M | 11.52M |
EBT including unusual items | 1.84B | 2.01B | 2.56B | 3.31B |
EBT excluding unusual items | 1.84B | 2.01B | 2.56B | 3.31B |
Income tax expense | 242.62M | 186.10M | 277.86M | 559.08M |
Effective tax rate | 13.21% | 9.25% | 10.87% | 16.88% |
Other operating expenses | - | - | - | - |
Net income | 1.59B | 1.83B | 2.28B | 2.75B |
Net profit margin | 29.82% | 31.25% | 33.88% | 33.50% |
Earnings per share | 1.27 | 1.47 | 1.82 | 2.20 |
Interest and investment income | 53.16M | 42.64M | 36.46M | 49.85M |
Interest expense | -40.88M | -39.33M | -34.20M | -36.76M |
Net interest expenses | 12.28M | 3.31M | 2.26M | 13.09M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.91B | 2.16B | 2.63B | 3.41B |
Gain or loss from assets sale | - | - | - | - |